KoreedaM, BrownL, ValdésLJIII (1990) The absolute stereochemistries of salvinorins. Chemistry Letters, 2015–2018;
2.
ValdésLIII, ButlerWM, HatfieldGM, PaulAG, KoreedaM. (1984) Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, Salvia divinorum. Journal of Organic Chemistry, 494716–4720;
3.
OrtegaA, BlountJF, ManchandPS. (1982) Salvinorin, a new trans-clerodane diterpene from Salvia divinorum (Labiatae). Journal of the Chemical Society, Perkin Transaction 1, 2505–2508.
4.
YanF, MosierPD, WestkaemperRB, StewartJ, ZjawionyJK, VorthermsTA, ShefflerDJ, RothBL. (2005) Identification of the molecular mechanisms by which the diterpenoid salvinorin A binds to κ-opioid receptors, Biochemistry, 448643–8651;
5.
RothBL, BanerK, WestkaemperR, SiebertDJ, RiceKC, SteinbergS, ErnsbergerP, RothmanRB. (2002) Salvinorin A: a potent naturally occurring nonnitrogenous opioid selective agonist. Proceedings of the National Academy of Science USA, 9911934–11939;
6.
SiebertDJ. (1994) Salvia divinorum and salvinorin A: new pharmacologic findings, Journal of Ethnopharmacology, 43, 53–56.
7.
ShirotaO, NagamatsuK, SekitaS. (2006Neoclerodane diterpenes from the hallucinogenic sage Salvia divinorum. Journal of Natural Products, 691782–1786;
8.
LeeDYW, MaZ, Liu-ChenL–Y, WangY, ChenY, CarlezonWAJr, CohenB. (2005) New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human K opioid receptors. Bioorganic and Medicinal Chemistry, 135635–5639;
9.
MunroTA, RizzacasaMA. (2003) Salvinorins D–F, new neoclerodane diterpenoids from Salvia divinorum, and an improved method for the isolation of salvinorin A. Journal of Natural Products, 66703–705;
10.
BighamAK, MunroTA, RizzacasaMA, BrowneRMB. (2003) Divinatorins A–C, new neoclerodane diterpenoids from the controlled sage Salvia divinorum, Journal of Natural Products, 661242–1244;
11.
ValdésLJIII, ChangH–M, VisgerDC, KoreedaM. (2001) Salvinorin C, a new neoclerodane diterpene from a bioactive fraction of the hallucinogenic Mexican mint Salvia divinorum. Organic Letters, 3, 3935–3937.
12.
Recent representative review: (a)PrisinzanoTE. (2009) Natural products as tools for neuroscience: Discovery and development of novel agents to treat drug abuse. Journal of Natural Products, 72581–587;
13.
PrisinzanoTE, RothmanRB. (2008) Salvinorin A analogs as probes in opioid pharmacology. Chemical Review, 1081732–1743;
14.
TidgewellK, ByrdN, CobbH, DerschCM, ButelmanER, RothmanRB, PrisinzanoTE. (2005) Neoclerodane diterpenes as a novel scaffold for opioid peceptor ligands. Journal of Medicinal Chemistry, 48, 4765–4771.
15.
ScheererJR, LawrenceJF, WangGC, EvansDA. (2007) Asymmetric synthesis of salvinorin A, a potent κ opioid receptor agonist. Journal of the American Chemical Society, 129, 8968–8969.
16.
NozawaM, SukaY, HoshiT, SuzukiT, HagiwaraH. (2008) Total synthesis of hallucinogenic neoclerodane diterpenoid, salvinorin A. Organic Letters, 10, 1365–1368.
17.
HagiwaraH, SukaY, NojimaT, HoshiT, SuzukiT. (2009) Second-generation synthesis of salvinorin A. Tetrahedron, 65, 4820–4825.
18.
HasegawaE, CurranDP. (1993) Additive and solvent effects on samarium diiodide reductions: the effects of water and DMPU. Journal of Organic Chemistry, 58, 5008–5010.
19.
Spectral data (1H- and 13C-NMR, IR and Mass) were identical with reported data including optical rotational value ([α]D −16.6 (c 0.424, CHCl3, lit. [3c] [α]D −20 (c 0.05, CHCl3).
